Submitted by reuters8361 in business
Roche <a href="https://www.reuters.com/markets/companies/ROG.S" target="_blank">(ROG.S)</a> agreed to take over unlisted obesity drug developer Carmot Therapeutics <a href="https://www.reuters.com/markets/companies/CRMO.O" target="_blank">(CRMO.O)</a> for $2.…